Literature DB >> 7542692

The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.

A Dabrowski1, A Gabryelewicz, L Chyczewski.   

Abstract

Acute hemorrhagic pancreatitis was induced in Wistar rats using a retrograde intraductal injection of 5% Na-taurocholate. Rats were treated with platelet-activating factor receptor (PAF) antagonist--BN 52021 (5 mg/kg) and sacrificed at 1 and 3 h after induction of acute pancreatitis. Malondialdehyde and sulfhydryl groups concentration were measured in pancreatic, lung, and liver tissue as a parameter of oxidant-antioxidant balance. We have shown that BN 52021 exerts only partial protecting effect against Na-TC-induced AP in rats. The positive effects of BN 52021 were expressed by: (1) Significant reduction of hyperamylasemia accompanied by lower malondialdehyde accumulation in pancreatic tissue; (2) Prevention of sulflhydryl groups depletion in lung tissue; (3) Diminution of necrotic and inflammatory changes in pancreatic tissue; and (4) Improvement of survival rate. We suggest that these effects may depend on the inhibition of PAF-mediated activation and oxidant generation by phagocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542692     DOI: 10.1007/BF02788536

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

2.  In vivo visualization of oxyradical-dependent photoemission during endothelium-granulocyte interaction in microvascular beds treated with platelet-activating factor.

Authors:  M Suematsu; I Kurose; H Asako; S Miura; M Tsuchiya
Journal:  J Biochem       Date:  1989-08       Impact factor: 3.387

3.  Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

Authors:  C Niederau; L D Ferrell; J H Grendell
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

4.  Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.

Authors:  W Zhou; M O McCollum; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

5.  Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.

Authors:  S J Konturek; A Dembinski; P J Konturek; Z Warzecha; J Jaworek; P Gustaw; R Tomaszewska; J Stachura
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

6.  The effect of acute nonbacterial dependent peritonitis on lung and liver oxidant stress and antioxidant activity.

Authors:  R Demling; R Daryani; C Campbell; J Knox; Y K Youn; C Lalonde
Journal:  Surgery       Date:  1993-09       Impact factor: 3.982

7.  Lung injury in acute experimental pancreatitis in rats. I. Morphological studies.

Authors:  S Willemer; C O Feddersen; W Karges; G Adler
Journal:  Int J Pancreatol       Date:  1991-05

8.  Oxidative stress. An early phenomenon characteristic of acute experimental pancreatitis.

Authors:  A Dabrowski; A Gabryelewicz
Journal:  Int J Pancreatol       Date:  1992-12

9.  Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

10.  A rapid, widely applicable screen for drugs that suppress free radical formation in ischemia/reperfusion.

Authors:  S C Salaris; C F Babbs
Journal:  J Pharmacol Methods       Date:  1988-12
View more
  7 in total

1.  Role of cytokines and their inhibitors in acute pancreatitis.

Authors:  A Kingsnorth
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

2.  Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis.

Authors:  E Folch; D Closa; N Prats; E Gelpí; J Roselló-Catafau
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

3.  Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells.

Authors:  B D Flickinger; M S Olson
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade.

Authors:  T Foitzik; H G Hotz; G Eibl; B Hotz; M Kirchengast; H J Buhr
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

5.  Differential oxidative injury in extrapancreatic tissues during experimental pancreatitis: modification of lung proteins by 4-hydroxynonenal.

Authors:  O Gilgenast; B Brandt-Nedelev; I Wiswedel; H Lippert; W Halangk; T Reinheckel
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

Review 6.  Role of platelet-activating factor in the pathogenesis of acute pancreatitis.

Authors:  Li-Rong Liu; Shi-Hai Xia
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

7.  The role of the intestine in the pathophysiology and management of severe acute pancreatitis.

Authors:  R S Flint; J A Windsor
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.